Denali Therapeutics Inc. DNLI
NASDAQ · United States · Health Technology
$20.52-0.15 (-0.73%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-06 | -0.68 | -0.51 | -32.5% | $3.60M | +67.3% | +1.7%$24.42→$24.83 |
| Q1 2026 | 2026-05-07 | -0.69 | -0.73 | +5.5% | — | — | -3.9%$20.41→$19.62 |
| Q4 2025 | 2026-02-26 | -0.73 | -0.75 | +2.7% | — | — | -5.0%$22.29→$21.18 |
| Q3 2025 | 2025-11-06 | -0.74 | -0.76 | +2.6% | — | — | +0.9%$14.89→$15.02 |
| Q2 2025 | 2025-08-11 | -0.72 | -0.74 | +2.7% | — | — | — |
| Q4 2023 | 2024-02-27 | -0.86 | -0.78 | -10.3% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.